New study aims to uncover why ECMO patients bleed
NCT ID NCT07580469
First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times
Summary
This study looks at how well platelets work in patients on a life-support machine called ECMO, which helps people with severe lung or heart problems. The goal is to understand why these patients often have dangerous bleeding. Researchers will measure platelet function over time and see if it relates to bleeding events. The study involves 40 adults in intensive care and does not test any new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD PLATELET DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UHToulouse
Toulouse, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new dissolvable dressing stop surgical bleeding faster?
- Can early blood transfusions save more trauma victims?
- Can a new device suck out deadly lung clots?
- Medical glue vs. internal bleeding: a new hope?
- Can a single stitch beat a double closure for TAVI patients?
- Can a sedative help rebuilt tissue survive after cancer surgery?